Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neutropenia 3 Neoplasms 2 Infections 2 Hematologic Neoplasms 2 Febrile Neutropenia 2 Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Migraine Disorders 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Hypokalemia 1 Hypertension 1

Interventions

Sorafenib 131 lenvatinib 115 Bevacizumab 88 Radiosurgery 69 atezolizumab 55 sintilimab 54 Nivolumab 51 durvalumab 43 Hepatectomy 43 Fluorouracil 42 apatinib 41 Oxaliplatin 41 camrelizumab 38 Radiofrequency Ablation 38 pembrolizumab 36 Radiotherapy 36 tislelizumab 35 Leucovorin 31 Magnetic Resonance Spectroscopy 30 Immune Checkpoint Inhibitors 28 Doxorubicin 28 Folfox protocol 26 tremelimumab 25 regorafenib 25 Cisplatin 20 spartalizumab 19 donafenib 19 Gemcitabine 19 Cyclophosphamide 19 toripalimab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Hepatocellular × Vancomycin × Clear all

NCT05690048 2025-08-06

FLORA

University Hospital Heidelberg

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡